Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bio-Techne Corp. buy Benchmark Co.

Start price
€71.50
18.08.23 / 50%
Target price
€110.44
18.08.24
Performance (%)
-5.59%
End price
€67.50
19.08.24
Summary
This prediction ended on 19.08.24 with a price of €67.50. With a performance of -5.59%, the BUY prediction by Benchmark_Co_ finished with a loss. Benchmark_Co_ has a follow-up prediction for Bio-Techne Corp. where he still thinks Bio-Techne Corp. is a Buy. Dividends of €0.30 are taken into consideration when calculating the performance. Benchmark_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Bio-Techne Corp. 1.429% 1.429% 10.078%
iShares Core DAX® -1.471% 1.895% 25.178%
iShares Nasdaq 100 -0.486% 4.395% 29.415%
iShares Nikkei 225® -2.115% 2.450% 20.561%
iShares S&P 500 0.394% 3.118% 29.456%

Comments by Benchmark_Co_ for this prediction

In the thread Bio-Techne Corp. diskutieren
Prediction Buy
Perf. (%) -5.59%
Target price 110.436
Change
Ends at 18.08.24

Bio-Techne Co. (NASDAQ: TECH) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $120.00 price target on the stock.
Ratings data for TECH provided by MarketBeat

In the thread Trading Bio-Techne Corp.
Prediction Buy
Perf. (%) -5.59%
Target price 110.436
Change
Ends at 18.08.24

Die von Benchmark_Co_ gewählte maximale Laufzeit wurde überschritten

Current prediction by Benchmark_Co_ for Bio-Techne Corp.

buy
Bio-Techne Corp.

Start price
Target price
Perf. (%)
€70.50
02.05.24
€88.85
02.05.25
0.92%
01.10.24

Stopped prediction by Benchmark_Co_ for Bio-Techne Corp.

buy
Bio-Techne Corp.

Start price
Target price
Perf. (%)
€67.00
13.08.24
€86.69
13.08.25
6.08%
01.10.24